Toward stratification of patients with pancreatic cancer: Past lessons from traditional approaches and future applications with physical biomarkers

Cancer Letters
Eugene J KoayJason B Fleming

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate and outcomes have not improved substantially for decades. Significant attention has focused on the biological drivers of the disease, and preclinical work has pointed to multiple biomarker candidates and therapeutic avenues. However, translation of these promising biomarkers and treatment strategies to patients has not been overwhelmingly successful. New strategies to account for the significant heterogeneity of the disease are needed so that rational treatments can be administered. Here, we focus on how physical sciences-based approaches may play a role in stratifying patients for clinical trials, and how this view of PDAC may reinvigorate treatment strategies that have been abandoned after "failing" to fulfill their potential in unselected patient populations. By complementing biological approaches, the development of physical biomarkers of PDAC may help deliver on the promise of personalized medicine for this devastating disease.

References

Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T Krusius, E Ruoslahti
Jan 1, 1997·Critical Reviews in Biochemistry and Molecular Biology·R V Iozzo
May 7, 1999·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·W Y Chen, G Abatangelo
May 18, 2000·JAMA : the Journal of the American Medical Association·S M GapsturA Dyer
Oct 2, 2003·Nature·Sarah P ThayerMatthias Hebrok
May 21, 2005·Nature Reviews. Cancer·Dan Laheru, Elizabeth M Jaffee
Jul 30, 2005·International Journal of Cancer. Journal International Du Cancer·Alexandre ChlenskiSusan L Cohn
Jul 26, 2006·Annals of Surgical Oncology·Gauri R VaradhacharyRobert A Wolff
Jan 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey R InfanteMichael Goggins
Jan 27, 2007·Blood·Karin FischerMarina Kreutz
Feb 3, 2007·Journal of Cellular Biochemistry·Gerald C ChuRonald A DePinho
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takeo NomiYoshiyuki Nakajima
Apr 7, 2007·Cancer Metastasis Reviews·Pawel SwietachAdrian L Harris
May 25, 2007·Nature Reviews. Molecular Cell Biology·Ralf H Adams, Kari Alitalo
Aug 7, 2007·Seminars in Oncology·Christopher H CraneRobert A Wolff
Jan 23, 2008·Langenbeck's Archives of Surgery·Chery Whipple, Murray Korc
Mar 12, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Douglas B Evans, UNKNOWN Multidisciplinary Pancreatic Cancer Study Group
May 7, 2008·Cancer Metastasis Reviews·Osvaldo L PodhajcerAndrea S Llera
May 9, 2008·The New England Journal of Medicine·Robert S Kerbel
Jun 11, 2008·Cancer Metastasis Reviews·Osvaldo L PodhajcerAndrea S Llera
Jul 29, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher H CraneChristopher G Willett
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hedy Lee KindlerRichard M Goldberg
Oct 6, 2010·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·J M OsborneH M Byrne
Oct 23, 2010·Gut·Albrecht NeesseDavid A Tuveson
Nov 4, 2010·The Oncologist·Matthew H G KatzPeter W T Pisters
Jan 13, 2011·Cancer Research·Hermann B FrieboesVittorio Cristini
Jan 1, 2010·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Kent E WilliamsAllan R Albig
Sep 17, 2011·Clinical & Developmental Immunology·Shigeo KoidoHisao Tajiri
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Aug 2, 2012·Nature Reviews. Clinical Oncology·Adriana AlbiniWilliam W Li
Nov 29, 2012·The Cancer Journal·Kevin C SoaresElizabeth M Jaffee
Jul 10, 2013·Proceedings of the National Academy of Sciences of the United States of America·Albrecht NeesseDavid A Tuveson
Oct 22, 2013·Cancer Letters·Serena LunardiThomas B Brunner
Jan 1, 2014·OncoTargets and Therapy·Albrecht NeessePatrick Michl
Mar 13, 2014·The Journal of Clinical Investigation·Eugene J KoayJason B Fleming

❮ Previous
Next ❯

Citations

Sep 10, 2016·World Journal of Gastroenterology : WJG·Chiara CaparelloElisa Giovannetti
Apr 17, 2021·International Immunopharmacology·Huan-Rong LanXue Yang
Dec 2, 2017·The Surgical Clinics of North America·Robert A Wolff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu
Alessandro PanicciaYuwen Zhu
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Katherine E PorukSean J Mulvihill
Biochimica Et Biophysica Acta
Estelle Leclerc, Stefan W Vetter
© 2021 Meta ULC. All rights reserved